Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/22/2014US20140142186 Methods of administering and evaluating nitrogen scavenging drugs for the treatment of hepatic encephalopathy
05/22/2014US20140142185 3-Benzyloxyphenyloxoacetic Acid Compounds for Reducing Uric Acid
05/22/2014US20140142184 Topical dapsone and dapsone/adaplene compositions and methods for use thereof
05/22/2014US20140142183 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
05/22/2014US20140142182 Aqueous Liquid Composition Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid
05/22/2014US20140142181 Treating and inhibiting recurrence of muscle cramps
05/22/2014US20140142180 Methods of treating tumors having elevated mct1 expression
05/22/2014US20140142177 Topical organic acid salt compositions suitable for treating infections
05/22/2014US20140142174 Darunavir formulations
05/22/2014US20140142173 Pharmaceutical composition for the prevention or treatment of a neurodegenerative disease, comprising a daphne genkwa extract or a compound isolated therefrom
05/22/2014US20140142172 Medical Food for Cognitive Decline
05/22/2014US20140142170 Composition and method for influencing energy metabolism and treating metabolic and other disorders
05/22/2014US20140142169 Sn-2-monoacylglycerols and lipid malabsorption
05/22/2014US20140142168 Methods and pharmaceutical compositions for the treatment of hormone-refractory prostate cancers
05/22/2014US20140142167 Micellar Preparation Containing Sparingly Water-Soluble Anticancer Agent And Novel Block Copolymer
05/22/2014US20140142166 Composition and method for delivery of hydrophobic active agents
05/22/2014US20140142165 Therapeutic particles suitable for parenteral administration and methods of making and using same
05/22/2014US20140142157 Extract of asplenium nidus l.
05/22/2014US20140142156 Non-Lactone Carbocyclic and Heterocyclic Antagonists and Agonists of Bacterial Quorum Sensing
05/22/2014US20140142155 Method of treating thrombocytopenia
05/22/2014US20140142154 Anti-fungal agent
05/22/2014US20140142153 Bendamustine formulations
05/22/2014US20140142152 Methods and compounds for treating cancer
05/22/2014US20140142151 Allantoin-containing skin cream
05/22/2014US20140142145 Combinations comprising a dipeptidylpeptidase - iv inhibitor
05/22/2014US20140142141 Deuterium-enriched lenalidomide
05/22/2014US20140142140 Pharmaceutical composition for neurological disorders
05/22/2014US20140142139 Dihydropyrazole gpr40 modulators
05/22/2014US20140142136 Enhanced Erythropoiesis and Iron Metabolism
05/22/2014US20140142134 Inhibitors of bacterial type iii secretion system
05/22/2014US20140142133 Modulation of cell barrier dysfunction
05/22/2014US20140142131 Long-acting injectable analgesic formulations for animals
05/22/2014US20140142129 Methods of treating a disease or disorder associated with bruton's tyrosine kinase
05/22/2014US20140142128 Methods of treating a disease or disorder associated with bruton's tyrosine kinase
05/22/2014US20140142127 Stable Compositions of HMG-COA Reductase Inhibitors and Omega-3 Oils
05/22/2014US20140142124 Compositions for Topical Application Having Androgenic Actions
05/22/2014US20140142118 Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
05/22/2014US20140142114 Anthelmintic compounds and compositions and method of using thereof
05/22/2014US20140142113 Method of treating inflammatory diseases using adenosine 2b receptor antagonists
05/22/2014US20140142112 Therapeutic agents useful for treating pain
05/22/2014US20140142109 Antifolate combinations
05/22/2014US20140142106 Method for treating peritoneal fibrosis
05/22/2014US20140142105 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
05/22/2014US20140142103 Methods and Compositions for Modulating Rad51 and Homologous Recombination
05/22/2014US20140142102 Cyclic amines as bromodomain inhibitors
05/22/2014US20140142099 Purinone Derivatives as Tyrosine Kinase Inhibitors
05/22/2014US20140142098 Triazolopyrazine
05/22/2014US20140142097 Pyridine-and pyrazine derivatives
05/22/2014US20140142095 Agents useful for treating friedreich's ataxia and other neurodegenerative diseases
05/22/2014US20140142092 Compounds and methods for skin repair
05/22/2014US20140142087 INHIBITORS OF PHOSPHATIDIC ACID PHOSPHOHYDROLASE (PAP), INCLUDING D-PROPRANOLOL AND ANALOGS THEREOF, ALONE OR IN COMBINATION WITH DESIPRAMINE, FOR THE TREATMENT OF CANCERS THAT DEPEND ON THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), ONCOGENIC VARIANTS THEREOF AND OTHER MEMBERS OF THE ErbB/HER FAMILY
05/22/2014US20140142085 Compounds for the treatment of hiv
05/22/2014US20140142079 Platinum compounds for treating cell proliferative diseases, preparation method and use thereof
05/22/2014US20140142077 Androgen pharmaceutical composition and method for treating depression
05/22/2014US20140142076 Oral transmucosal drug delivery system
05/22/2014US20140142075 Methods and compositions for locally increasing body fat
05/22/2014US20140142074 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
05/22/2014US20140142073 Aqueous based capsaicinoid formulations and methods of manufacture and use
05/22/2014US20140142072 Composition comprising a diindolylmethane and a retinoid to treat a skin condition
05/22/2014US20140142071 Regression of arterial plaque
05/22/2014US20140142070 Darunavir combination formulations
05/22/2014US20140142069 Substituted 3-phenylpropionic acids and the use thereof
05/22/2014US20140142066 Pharmaceutical compositions for preventing and treating eye pathologies
05/22/2014US20140142063 Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
05/22/2014US20140142061 Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome
05/22/2014US20140142060 Method and device for identification of one carbon pathway gene variants as stroke risk markers, combined data mining, logistic regression, and pathway analysis
05/22/2014US20140142058 Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine
05/22/2014US20140142056 Methods of treating cancer with glut inhibitors and oxidative phosphorylation inhibitors
05/22/2014US20140142055 Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence
05/22/2014US20140142053 Use of a Composition Comprising Acylated Steryl Glucoside in the Manufacture of a Product
05/22/2014US20140142052 Phosphorylated polyols, pyrophosphates, and derivatives thereof having biological activity
05/22/2014US20140142043 Inhibition of drug resistant cancer cells
05/22/2014US20140142042 Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations
05/22/2014US20140142038 Angiogenically effective unit dose of fgf and method of administering
05/22/2014US20140142024 Bpi and its congeners as radiation mitigators and radiation protectors
05/22/2014US20140141510 Medicament for liver regeneration and for treatment of liver failure
05/22/2014US20140141102 Trimegestone (tmg) for treatment of preterm birth
05/22/2014US20140141100 Compounds and Methods for Appetite Suppression and Weight Control
05/22/2014US20140141099 Drug discovery methods
05/22/2014US20140141095 Use of deuterium depleted water for the treatment of insulin resistance
05/22/2014US20140141091 Fexofenadine microcapsules and compositions containing them
05/22/2014US20140141090 Pharmaceutical Composition Comprising Opioid Agonist And Sequestered Antagonist
05/22/2014US20140141089 Nanoparticles, Compositions Thereof, and Methods of Use, and Methods of Making the Same
05/22/2014US20140141088 Water-Soluble Anti-Inflammatory Cream with Natural Ingredients Base
05/22/2014US20140141087 Oral Composition Comprising An Antacid, an Anaesthetic and an Inorganic Matrix Comprising Silicon Dioxide and Titanium Dioxide
05/22/2014US20140141086 Injectable Depot Compositions and Uses Thereof
05/22/2014US20140141084 Hypoxia-responsive nanoparticle for therapy and imaging of hypoxia-involving diseases
05/22/2014US20140141083 Nanoparticulate meloxicam formulations
05/22/2014US20140141082 Compositions Containing Enriched Natural Crocin and/or Crocetin, and Their Therapeutic or Nutraceutical Uses
05/22/2014US20140141080 Pharmaceutical compositions for the coordinated delivery of nsaids
05/22/2014US20140141079 Pramipexole once-daily dosage form
05/22/2014US20140141077 Composition for use in treating and preventing inflammation related disorder
05/22/2014US20140141076 Soft capsule preparation, composition for soft capsule preparation, and method of producing soft capsule preparation
05/22/2014US20140141075 5-aminosalicylic acid capsule formulation
05/22/2014US20140141074 Concentrated therapeutic phospholipid compositions
05/22/2014US20140141072 Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
05/22/2014US20140141071 Orally administrable liposomally encapsulated reduced glutathione, with n-o enhancing compounds for reversal and prevention of oxidation of cholesterol and of low density lipoprotein
05/22/2014US20140141069 Beta-guanidinopropionic acid for the treatment of hypertension
05/22/2014US20140141066 Encapsulated Ascorbic Acid Composition
05/22/2014US20140141065 Method to achieve extended expression of dna infused into liver
1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 7860